Skip Navigation
Skip to contents

Ann Dermatol.  2011 Feb;23(1):53-60. 10.5021/ad.2011.23.1.53.

A Two-week Interval Is Better Than a Three-week Interval for Reducing the Recurrence Rate of Hand-foot Viral Warts after Cryotherapy: A Retrospective Review of 560 Hand-foot Viral Warts Patients

Affiliations
  • 1Department of Dermatology, College of Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea. anpark7770@hanmail.net

Abstract

BACKGROUND
Viral warts are a common infectious disease and liquid nitrogen cryotherapy is one of the most common methods for treatment of these warts. Hand-foot viral warts frequently recur and reduce quality of life as well.
OBJECTIVE
To find the ideal treatment interval between cryotherapy sessions that can influence not only the cure rate but also the recurrence rate for hand-foot viral warts.
METHODS
A retrospective study was designed to compare a 2 week interval and a 3 week interval between cryotherapy sessions on hand-foot viral warts with respect to cure rate, recurrence rate, treatment number, duration of treatment, mean time to recurrence and adverse events.
RESULTS
A total of 560 patients were enrolled. The overall cure rate was 75.7% and the recurrence rate was 19.6%. The mean time to recurrence was 7.8 months (range 1~26 months). For the 2-week and 3-week groups, cure rates were, respectively, 76.6% (196) and 75.0% (228); recurrence rates were 13.3% (26) and 25.0% (57). The mean time to recurrence was 9.8 months and 6.9 months, respectively. Adverse events were not statistically different.
CONCLUSION
We suggested that 2-week cryotherapy is optimal not only because of the rapid cure but also because of the lower recurrence rate and similar adverse events.

Keyword

Cryotherapy; Recurrence rate; Treatment interval; Verruca; Wart

MeSH Terms

Communicable Diseases
Cryotherapy
Humans
Nitrogen
Quality of Life
Recurrence
Retrospective Studies
Warts
Nitrogen
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr